OMCL Gene Therapy Working Group
27 - 28 March 2025, Brussels, Belgium
The OMCL Gene Therapy Working Group held its latest meeting on 27-28 March 2025. This two-day event, hosted by Sciensano at their premises in Brussels (Belgium), brought together members of the group to promote collaboration and knowledge sharing and welcomed five external experts for an open session for exchange on the latest technologies and challenges.
The group members participated in closed working sessions focused on ongoing studies, with AAV vector analysis once again the central topic. The discussions also explored opportunities for broadening the scope to include other vector systems, alongside strategic planning for upcoming initiatives and future projects; building up laboratory capacity remained a key priority throughout.
The open session featured five guest speakers who shared valuable insights on recent data, market tendencies and challenges faced in the field. These interactions helped spark ideas for future collaboration and brought a fresh perspective to the group’s work.
Beyond the formal discussions, the event offered an opportunity for networking and informal exchange in a warm and collegial atmosphere, encouraging valuable connections and synergy.